RETEVMO
- Product NDC
- 0002-6082
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- selpercatinib
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Labeler
- Eli Lilly and Company
- Application
- NDA218160
- Marketing category
- NDA
- Substance
- SELPERCATINIB
- Current FDA listing
- Yes
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|
| 0002-6082-60 | 60 TABLET, COATED in 1 BOTTLE (0002-6082-60) | 2024-04-10 | | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| RETEVMO | Eli Lilly and Company | Loxo Oncology, Inc. | 2025-11-20 | HUMAN PRESCRIPTION DRUG LABEL | 22 |